BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 15313087)

  • 1. Physician barriers to population-based, fecal occult blood test-based colorectal cancer screening programs for average-risk patients.
    McGregor S; Hilsden R; Yang H
    Can J Gastroenterol; 2010 Jun; 24(6):359-64. PubMed ID: 20559577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ColonCancerCheck primary care invitation pilot project: patient perceptions.
    Tinmouth J; Ritvo P; McGregor SE; Patel J; Guglietti C; Levitt CA; Paszat LF; Rabeneck L
    Can Fam Physician; 2013 Dec; 59(12):e541-9. PubMed ID: 24336559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactions to a targeted intervention to increase fecal occult blood testing among average-risk adults waiting for screening colonoscopy.
    McGregor SE; Ritvo P; Tinmouth J; Kornblum A; Myers R; Hilsden RJ; Paszat LF; Rabeneck L
    Can J Gastroenterol; 2011 May; 25(5):248-52. PubMed ID: 21647457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal Cancer Prevention Policies: A Qualitative Systematic Review and Meta-Synthesis.
    Kabiri N; Khodayari-Zarnaq R; Khoshbaten M; Janati A
    Int J Prev Med; 2022; 13():8. PubMed ID: 35281982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General practitioners' perceptions of population based bowel screening and their influence on practice: a qualitative study.
    Dawson G; Crane M; Lyons C; Burnham A; Bowman T; Perez D; Travaglia J
    BMC Fam Pract; 2017 Mar; 18(1):36. PubMed ID: 28298185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of FOBT vs. FIT: A meta-analysis on colorectal cancer screening test.
    Mousavinezhad M; Majdzadeh R; Akbari Sari A; Delavari A; Mohtasham F
    Med J Islam Repub Iran; 2016; 30():366. PubMed ID: 27493910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychological Barriers and Facilitators of Colorectal Cancer Screening: A French Qualitative Study.
    Bridou M; Aguerre C; Gimenes G; Kubiszewski V; Le Gall A; Potard C; Sorel O; Reveillere C
    Health Psychol Res; 2013 Apr; 1(2):e22. PubMed ID: 26973907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social Cognitive Mediators of Sociodemographic Differences in Colorectal Cancer Screening Uptake.
    Lo SH; Waller J; Vrinten C; Kobayashi L; von Wagner C
    Biomed Res Int; 2015; 2015():165074. PubMed ID: 26504782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with use and non-use of the Fecal Immunochemical Test (FIT) kit for Colorectal Cancer Screening in Response to a 2012 outreach screening program: a survey study.
    Gordon NP; Green BB
    BMC Public Health; 2015 Jun; 15():546. PubMed ID: 26062732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reasons for non-uptake and subsequent participation in the NHS Bowel Cancer Screening Programme: a qualitative study.
    Palmer CK; Thomas MC; von Wagner C; Raine R
    Br J Cancer; 2014 Apr; 110(7):1705-11. PubMed ID: 24619071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioural and demographic predictors of adherence to three consecutive faecal occult blood test screening opportunities: a population study.
    Duncan A; Turnbull D; Wilson C; Osborne JM; Cole SR; Flight I; Young GP
    BMC Public Health; 2014 Mar; 14():238. PubMed ID: 24606951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes and beliefs of non-participants in a population-based screening programme for colorectal cancer.
    Hall NJ; Rubin GP; Dobson C; Weller D; Wardle J; Ritchie M; Rees CJ
    Health Expect; 2015 Oct; 18(5):1645-57. PubMed ID: 24268129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with intentions to adhere to colorectal cancer screening follow-up exams.
    Zheng YF; Saito T; Takahashi M; Ishibashi T; Kai I
    BMC Public Health; 2006 Nov; 6():272. PubMed ID: 17083746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The view from two sides: a qualitative study of community and medical perspectives on screening for colorectal cancer using FOBT.
    Clavarino AM; Janda M; Hughes KL; Del Mar C; Tong S; Stanton WR; Aitken JF; Leggett BA; Newman B
    Prev Med; 2004 Sep; 39(3):482-90. PubMed ID: 15313087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Would general practitioners support a population-based colorectal cancer screening programme of faecal-occult blood testing?
    Tong S; Hughes K; Oldenburg B; Del Mar C
    Intern Med J; 2004; 34(9-10):532-8. PubMed ID: 15482265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survey on colorectal cancer screening knowledge, attitudes, and practices of general practice physicians in Lazio, Italy.
    Federici A; Giorgi Rossi P; Bartolozzi F; Farchi S; Borgia P; Guasticchi G
    Prev Med; 2005 Jul; 41(1):30-5. PubMed ID: 15916990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer screening practise is influenced by ethnicity of medical practitioner and patient.
    Koo JH; You MY; Liu K; Athureliya MD; Tang CW; Redmond DM; Connor SJ; Leong RW
    J Gastroenterol Hepatol; 2012 Feb; 27(2):390-6. PubMed ID: 21793910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How equitable are colorectal cancer screening programs which include FOBTs? A review of qualitative and quantitative studies.
    Javanparast S; Ward P; Young G; Wilson C; Carter S; Misan G; Cole S; Jiwa M; Tsourtos G; Martini A; Gill T; Baratiny G; Matt MA
    Prev Med; 2010 Apr; 50(4):165-72. PubMed ID: 20153359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecal occult blood test as a screening test for colorectal cancer.
    Janssens JF
    Acta Gastroenterol Belg; 2005; 68(2):244-6. PubMed ID: 16013643
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.